HKD 7.71
(0.13%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 69.77 Million CNY | -9.3% |
2022 | 76.92 Million CNY | 69.74% |
2021 | 45.31 Million CNY | 22.92% |
2020 | 36.87 Million CNY | 91.29% |
2019 | 19.27 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 19.18 Million CNY | 0.0% |
2024 Q1 | 19.18 Million CNY | -6.28% |
2023 FY | 69.77 Million CNY | -9.3% |
2023 Q1 | 12.79 Million CNY | -58.39% |
2023 Q4 | 20.46 Million CNY | 30.12% |
2023 Q3 | 15.73 Million HKD | 22.91% |
2023 Q2 | 12.79 Million CNY | 0.0% |
2022 Q2 | 22.45 Million CNY | 0.0% |
2022 Q1 | 22.45 Million CNY | -10.4% |
2022 FY | 76.92 Million CNY | 69.74% |
2022 Q4 | 30.75 Million CNY | 0.0% |
2022 Q3 | 30.75 Million CNY | 36.95% |
2021 Q1 | 8.36 Million CNY | 0.0% |
2021 FY | 45.31 Million CNY | 22.92% |
2021 Q4 | 25.06 Million CNY | 0.0% |
2021 Q3 | 25.06 Million CNY | 199.72% |
2021 Q2 | 8.36 Million CNY | 0.0% |
2020 FY | 36.87 Million CNY | 91.29% |
2019 FY | 19.27 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Life Healthcare Group Limited | 20.15 Million HKD | -246.167% |
China Biotech Services Holdings Limited | 161.99 Million HKD | 56.932% |